| 20.3 -0.22 (-1.07%) | 12-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 24.99 | 1-year : | 26.47 |
| Resists | First : | 21.4 | Second : | 22.67 |
| Pivot price | 21.15 |
|||
| Supports | First : | 19.35 | Second : | 16.09 |
| MAs | MA(5) : | 20.14 |
MA(20) : | 20.96 |
| MA(100) : | 18.9 |
MA(250) : | 19.86 |
|
| MACD | MACD : | 0 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 27.7 |
D(3) : | 20.2 |
| RSI | RSI(14): 46.5 |
|||
| 52-week | High : | 25.63 | Low : | 15.14 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ NVST ] has closed above bottom band by 27.5%. Bollinger Bands are 43.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 20.9 - 21 | 21 - 21.08 |
| Low: | 20 - 20.14 | 20.14 - 20.25 |
| Close: | 20.11 - 20.32 | 20.32 - 20.49 |
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Fri, 13 Dec 2024
Quantinno Capital Management LP Has $1.10 Million Position in Envista Holdings Co. (NYSE:NVST) - MarketBeat
Thu, 12 Dec 2024
Reasons to Retain Envista Stock in Your Portfolio for Now - Yahoo Finance
Thu, 12 Dec 2024
35,631 Shares in Envista Holdings Co. (NYSE:NVST) Purchased by XTX Topco Ltd - MarketBeat
Wed, 11 Dec 2024
Envista Announces Participation in Evercore HealthCONx Conference - The Eastern Progress Online
Wed, 11 Dec 2024
Envista Holdings Co. (NYSE:NVST) Shares Sold by Rockefeller Capital Management L.P. - MarketBeat
Tue, 10 Dec 2024
Envista Holdings Insiders Land Bargain With Gains Of US$184k - Simply Wall St
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 172 (M) |
| Shares Float | 171 (M) |
| Held by Insiders | 0.7 (%) |
| Held by Institutions | 114.4 (%) |
| Shares Short | 11,520 (K) |
| Shares Short P.Month | 15,390 (K) |
| EPS | -7.83 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 17.86 |
| Profit Margin | -53.5 % |
| Operating Margin | 3.7 % |
| Return on Assets (ttm) | 1.6 % |
| Return on Equity (ttm) | -36.4 % |
| Qtrly Rev. Growth | -4.9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 14.52 |
| EBITDA (p.s.) | 1.7 |
| Qtrly Earnings Growth | -60.3 % |
| Operating Cash Flow | 306 (M) |
| Levered Free Cash Flow | 351 (M) |
| PE Ratio | -2.6 |
| PEG Ratio | 0 |
| Price to Book value | 1.13 |
| Price to Sales | 1.39 |
| Price to Cash Flow | 11.41 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|